computed tomography (CT) and magnetic resonance imaging (MRI) features of pancreatic neuroendocrine neoplasm (pNEN).
Methods:
CT and MRI data of 143 patients with pNEN confirmed by surgery and pathology from February 2009 to September 2020 were retrospectively analyzed. The lesions were divided into four groups including neuroendocrine tumor (NET) G1
NET G2
NET G3 and neuroendocrine carcinoma (NEC) G3. Image analysis included tumor location
size
shape
edge
density or signal intensity
enhancement characteristics
main pancreatic duct dilatation
peripheral invasion and metastasis.
Results:
A total of 149 lesions were detected in 143 patients. The number of NET G1
NET G2
NET G3 and NEC G3 lesions was 63
74
8 and 4
respectively. NEC G3 group had the largest lesion (average diameter was 5.75 cm)
and NET G1 group had the smallest lesion (average diameter was 2.24 cm). There were 127 (85.2%) round-like lesions and 22 (14.8%) irregular lesions. 130 (87.2%) lesions were iso-density on CT plain scan
and 19 (12.8%) lesions were slightly low density. 124 (83.2%) lesions appeared hyperintense or slightly high signal intensity on T2-weighted imaging (T2WI)
146 (98.0%) lesions appeared moderately or slightly hypointense on T1-weighted imaging (T1WI)
and all 130 lesions showed high signal intensity on diffusion-weighted imaging (DWI). Clear margin in 76 (51.0%) lesions
cysts in 57 (38.3%) lesions
calcification in 22 (14.8%) lesions
pancreatic duct dilatation in 14 (9.4%) lesions
distal pancreatic atrophy in 9 (6.0%) lesions
peripancreatic invasion in 30 (20.1%) lesions
lymph node metastasis in 14 (9.4%) lesions
and liver metastasis in 15 (10.1%) lesions were found. After contrast-enhancement
92 (61.8%) lesions showed continuous significant enhancement on CT images
and 115 (77.2%) lesions showed obvious enhancement on arterial phase images with its degrees higher than the pancreas and continuous contrast-enhancement. Four lesions of NEC G3 appeared slightly contrast enha
ncement with degrees lower than the pancreas all the time.
Conclusion:
The typical CT and MRI manifestations of pancreatic neuroendocrine neoplasms are round-like nodules or masses. The lesions are equal or slightly low density on CT plain scan and low or slightly low signal intensity on T1WI. After contrast enhancement
most of the low-grade tumors showed obvious continuous enhancement
while most of the high-grade neoplasms showed slightly contrast enhancement on all phase images with its degrees lower than the pancreas.